News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
709,394 Results
Type
Article (42653)
Company Profile (435)
Press Release (666306)
Section
Business (208677)
Career Advice (2023)
Deals (35998)
Drug Delivery (102)
Drug Development (83616)
Employer Resources (170)
FDA (16387)
Job Trends (15081)
News (352709)
Policy (33048)
Tag
Academia (2645)
Alliances (50870)
Alzheimer's disease (1397)
Approvals (16359)
Artificial intelligence (215)
Bankruptcy (367)
Best Places to Work (11850)
Biotechnology (329)
Breast cancer (231)
Cancer (1759)
Cardiovascular disease (138)
Career advice (1685)
CAR-T (127)
Cell therapy (374)
Clinical research (67116)
Collaboration (699)
Compensation (375)
COVID-19 (2626)
C-suite (167)
Data (1656)
Diabetes (217)
Diagnostics (6351)
Earnings (86678)
Employer resources (147)
Events (114426)
Executive appointments (578)
FDA (17306)
Funding (631)
Gene therapy (267)
GLP-1 (687)
Government (4449)
Healthcare (19115)
Infectious disease (2739)
Inflammatory bowel disease (127)
Interviews (311)
IPO (16744)
Job creations (3701)
Job search strategy (1435)
Layoffs (466)
Legal (7962)
Lung cancer (260)
Manufacturing (244)
Medical device (13423)
Medtech (13428)
Mergers & acquisitions (19620)
Metabolic disorders (581)
Neuroscience (1831)
NextGen: Class of 2025 (6762)
Non-profit (4554)
Northern California (2119)
Obesity (325)
Opinion (212)
Patents (164)
People (58229)
Phase I (21070)
Phase II (29634)
Phase III (21881)
Pipeline (729)
Postmarket research (2610)
Preclinical (8988)
Radiopharmaceuticals (257)
Rare diseases (344)
Real estate (6008)
Regulatory (22403)
Research institute (2420)
Resumes & cover letters (352)
Southern California (1826)
Startups (3757)
United States (18963)
Vaccines (630)
Weight loss (227)
Date
Today (35)
Last 7 days (609)
Last 30 days (2677)
Last 365 days (35512)
2025 (4563)
2024 (36311)
2023 (41037)
2022 (52312)
2021 (56794)
2020 (54951)
2019 (47471)
2018 (35732)
2017 (33073)
2016 (32428)
2015 (38466)
2014 (32283)
2013 (27219)
2012 (29322)
2011 (29939)
2010 (28074)
Location
Africa (735)
Arizona (219)
Asia (39000)
Australia (6507)
California (4887)
Canada (1727)
China (403)
Colorado (221)
Connecticut (242)
Europe (85170)
Florida (693)
Georgia (165)
Illinois (471)
Indiana (262)
Maryland (759)
Massachusetts (3757)
Michigan (200)
Minnesota (340)
New Jersey (1375)
New York (1380)
North Carolina (897)
Northern California (2119)
Ohio (175)
Pennsylvania (1112)
South America (1109)
Southern California (1826)
Texas (717)
Utah (145)
Washington State (485)
709,394 Results for "cognition therapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Stonegate Capital Partners Initiates Coverage on Alpha Cognition Inc. (ACOG)
January 30, 2025
·
1 min read
Press Releases
Cognition Therapeutics CEO Participating in Longwood and Sachs Conferences
January 9, 2025
·
5 min read
Press Releases
Cognition Therapeutics Announces Publication of Commercial Manufacturing Process for Lead Alzheimer’s Candidate, Zervimesine (CT1812)
February 21, 2025
·
6 min read
Press Releases
Cognition Therapeutics’ Analysis Correlates Biomarker Changes with Cognitive Benefit in Alzheimer’s Population
November 25, 2024
·
9 min read
Business
Cognition Therapeutics Reports Financial Results for the First Quarter 2024 and Provides Business Update
Cognition Therapeutics, Inc. reported financial results for the first quarter ended March 31, 2024, and provided a business update.
May 7, 2024
·
7 min read
Press Releases
Cognition’s Positive Phase 2 ‘SHIMMER’ Study of Zervimesine (CT1812) in Dementia with Lewy Bodies (DLB) will be Presented in a Podium Presentation at ILBDC
January 30, 2025
·
9 min read
Pharm Country
Cognition Therapeutics KOL Event Provided Platform for Valuable Discussion of Current Therapeutic Options and Need for Additional Options to Treat Alzheimer’s Disease
Cognition Therapeutics, Inc provided a recap of the virtual KOL event hosted on April 12, 2024.
April 22, 2024
·
8 min read
Press Releases
Cognition Therapeutics Announces Positive Results in Phase 2 Study of CT1812 in Dementia with Lewy Bodies
December 18, 2024
·
11 min read
Pharm Country
Cognition Therapeutics to Present at the Needham Virtual Healthcare Conference - April 02, 2024
Cognition Therapeutics, Inc. announced that the Company’s president and CEO, Lisa Ricciardi, will present at the 23rd Annual Needham Virtual Healthcare Conference taking place April 8-11, 2024.
April 2, 2024
·
5 min read
Press Releases
INmune Bio Inc. to Host Webinar on Cognitive Testing Using EMACC and CDR-SB
October 28, 2024
·
6 min read
1 of 70,940
Next
